Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).
Tomas JelinekJana MihalyovaMichal KascakJuraj DurasTereza PopkovaKaterina BenkovaPetra RichterovaHana PlonkovaJana ZuchnickaLucie BroskevicovaLucie HuvarovaLucie CernaKaterina GrowkovaMichal SimicekMartin HavelJaromir GumulecMilan NavratilZdenek KoristekBruno PaivaRoman HajekPublished in: American journal of hematology (2018)